argenx SE

554.40 0.95%
EURONEXT: ARGX.BR
Market Cap.: 33.2 B L
P/E: -780.85 x3.3
EPS: -0.71 x 5.9
Earnings Call
3 months, 2 weeks from now
Dividend Waiting Time
n.A.
Latest Dividends History
Yield
Payout
Volume Level
μ 54,691
51,600 Moderate Low
Performance Ranks (Intraday)
Netherlands:

17th

out of

98

Healthcare:

212th

out of

792

Biotechnology:

85th

out of

227

Peer Group:

1st

out of

4

About

argenx SE, a biotechnology company, focuses on developing various therapies for the treatment of autoimmune diseases in the United States, the Netherlands, Belgium, Japan, Switzerland, Germany and France. Its lead product candidate is efgartigimod for …